EcoDrugPlus

Predicted Pseudogene 5244

Ensembl ID : ENSMSIG00000015630
Gene Symbol: GM5244
1 Cross references
183 Possible Orthologues:

Presenilin 1

Ensembl ID : ENSMSIG00000002158
Gene Symbol: PSEN1
1 Cross references
215 Possible Orthologues:

Presenilin 2

Ensembl ID : ENSMSIG00000007254
Gene Symbol: PSEN2
1 Cross references
220 Possible Orthologues:

Presenilin Enhancer Gamma Secretase Subunit

Ensembl ID : ENSMSIG00000005677
Gene Symbol: PSENEN
1 Cross references
196 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSMSIG00000023362
Gene Symbol: PGR
1 Cross references
208 Possible Orthologues:

Prostaglandin D Receptor

Ensembl ID : ENSMSIG00000014308
Gene Symbol: PTGDR
1 Cross references
133 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSMSIG00000030552
Gene Symbol: PTGDR2
1 Cross references
221 Possible Orthologues:

Prostaglandin E Receptor 1 (Subtype Ep1)

Ensembl ID : ENSMSIG00000011721
Gene Symbol: PTGER1
1 Cross references
250 Possible Orthologues:

Prostaglandin E Receptor 2 (Subtype Ep2)

Ensembl ID : ENSMSIG00000027338
Gene Symbol: PTGER2
1 Cross references
256 Possible Orthologues:

Prostaglandin E Receptor 3 (Subtype Ep3)

Ensembl ID : ENSMSIG00000005959
Gene Symbol: PTGER3
1 Cross references
209 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4)

Ensembl ID : ENSMSIG00000031824
Gene Symbol: PTGER4
1 Cross references
289 Possible Orthologues:

Prostaglandin I Receptor (Ip)

Ensembl ID : ENSMSIG00000011655
Gene Symbol: PTGIR
1 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).